TY - JOUR
T1 - Hepatitis B virus infection and vaccine-induced immunity in Madrid (Spain)
AU - Pedraza-Flechas, Ana María
AU - García-Comas, Luis
AU - Ordobás-Gavín, María
AU - Sanz-Moreno, Juan Carlos
AU - Ramos-Blázquez, Belén
AU - Astray-Mochales, Jenaro
AU - Moreno-Guillén, Santiago
N1 - Publisher Copyright:
© 2013.
PY - 2014
Y1 - 2014
N2 - Objective: To estimate the prevalence of hepatitis B virus (HBV) infection and vaccine-induced immunity in the region of Madrid, and to analyze their evolution over time. Methods: An observational, analytical, cross-sectional study was carried out in the population aged 16-80 years between 2008 and 2009. This was the last of four seroprevalence surveys in the region of Madrid. The prevalence of HBV infection and vaccine-induced immunity was estimated using multivariate logistic models and were compared with the prevalences in the 1989, 1993 and 1999 surveys. Results: In the population aged 16-80 years, the prevalence of HBV infection was 11.0% (95% CI: 9.8-12.3) and that of chronic infection was 0.7% (95% CI: 0.5-1.1). The prevalence of vaccine-induced immunity in the population aged 16-20 years was 73.0% (95% CI: 70.0-76.0). Compared with previous surveys, there was a decrease in the prevalence of HBV infection. Conclusions: Based on the prevalence of chronic infection (<1%), Madrid is a region with low HBV endemicity. Preventive strategies against HBV should especially target the immigrant population.
AB - Objective: To estimate the prevalence of hepatitis B virus (HBV) infection and vaccine-induced immunity in the region of Madrid, and to analyze their evolution over time. Methods: An observational, analytical, cross-sectional study was carried out in the population aged 16-80 years between 2008 and 2009. This was the last of four seroprevalence surveys in the region of Madrid. The prevalence of HBV infection and vaccine-induced immunity was estimated using multivariate logistic models and were compared with the prevalences in the 1989, 1993 and 1999 surveys. Results: In the population aged 16-80 years, the prevalence of HBV infection was 11.0% (95% CI: 9.8-12.3) and that of chronic infection was 0.7% (95% CI: 0.5-1.1). The prevalence of vaccine-induced immunity in the population aged 16-20 years was 73.0% (95% CI: 70.0-76.0). Compared with previous surveys, there was a decrease in the prevalence of HBV infection. Conclusions: Based on the prevalence of chronic infection (<1%), Madrid is a region with low HBV endemicity. Preventive strategies against HBV should especially target the immigrant population.
UR - http://www.scopus.com/inward/record.url?scp=84924068442&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84924068442&partnerID=8YFLogxK
U2 - 10.1016/j.gaceta.2014.05.007
DO - 10.1016/j.gaceta.2014.05.007
M3 - Research Article
C2 - 25042394
AN - SCOPUS:84924068442
SN - 0213-9111
VL - 28
SP - 492
EP - 495
JO - Gaceta Sanitaria
JF - Gaceta Sanitaria
IS - 6
ER -
